Literature DB >> 22119505

Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health Study.

Thanh G N Ton1, Samay Jain, Mary L Biggs, Evan L Thacker, Elsa S Strotmeyer, Robert Boudreau, Anne B Newman, W T Longstreth, Harvey Checkoway.   

Abstract

BACKGROUND: Studies demonstrate existence of inflammation in prevalent Parkinson's disease (PD). We assessed associations of baseline levels of inflammatory markers with prevalent PD at baseline (1989) and incident PD identified over 13 years of follow-up of the Cardiovascular Health Study.
METHODS: Blood samples at baseline were measured for fibrinogen, interleukin-6, tumor necrosis factor-α, C-reactive protein, albumin, and white blood cells. The analysis included 60 prevalent and 154 incident PD cases.
RESULTS: Risk of prevalent PD was significantly higher per doubling of IL-6 among women (odds ratio [OR]=1.5, 95% confidence interval [CI]: 1.0, 2.4) and WBC among men (OR: 2.4, 95% CI: 1.2, 4.9) in multivariate models. Risk of incident PD was not associated with higher levels of any biomarker after adjusting for age, smoking, African American race, and history of diabetes. Inverse associations with incident PD were observed per doubling of C-reactive protein (OR=0.9; 95% CI: 0.8, 1.0) and of fibrinogen among women (OR=0.4; 95% CI: 0.2, 0.8).
CONCLUSIONS: Although inflammation exists in PD, it may not represent an etiologic factor. Our findings suggest the need for larger studies that measure inflammatory markers before PD onset. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119505      PMCID: PMC3288759          DOI: 10.1016/j.parkreldis.2011.11.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  26 in total

Review 1.  Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

2.  Serum inflammatory biomarkers in Parkinson's disease.

Authors:  M Dufek; M Hamanová; J Lokaj; D Goldemund; I Rektorová; Z Michálková; K Sheardová; I Rektor
Journal:  Parkinsonism Relat Disord       Date:  2008-07-30       Impact factor: 4.891

3.  A possible role for humoral immunity in the pathogenesis of Parkinson's disease.

Authors:  Carolyn F Orr; Dominic B Rowe; Yoshikuni Mizuno; Hideo Mori; Glenda M Halliday
Journal:  Brain       Date:  2005-10-11       Impact factor: 13.501

Review 4.  Non-steroidal anti-inflammatory drugs in Parkinson's disease.

Authors:  Ennio Esposito; Vincenzo Di Matteo; Arcangelo Benigno; Massimo Pierucci; Giuseppe Crescimanno; Giuseppe Di Giovanni
Journal:  Exp Neurol       Date:  2007-02-23       Impact factor: 5.330

Review 5.  Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.

Authors:  Andis Klegeris; Patrick L McGeer
Journal:  Curr Alzheimer Res       Date:  2005-07       Impact factor: 3.498

Review 6.  Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.

Authors:  T Nagatsu; M Sawada
Journal:  J Neural Transm Suppl       Date:  2007

7.  Peripheral inflammatory biomarkers and risk of Parkinson's disease.

Authors:  Honglei Chen; Eilis J O'Reilly; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2007-09-22       Impact factor: 4.897

8.  Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study.

Authors:  Christopher Keller; Ronit Katz; Mark J Sarnak; Linda F Fried; Bryan Kestenbaum; Mary Cushman; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2009-09-03       Impact factor: 5.992

Review 9.  Inflammation in Parkinson's disease: causative or epiphenomenal?

Authors:  Andreas Hald; Johan Van Beek; Julie Lotharius
Journal:  Subcell Biochem       Date:  2007

10.  Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.

Authors:  In-Uk Song; Joong-Seok Kim; Sung-Woo Chung; Kwang-Soo Lee
Journal:  Eur Neurol       Date:  2009-06-12       Impact factor: 1.710

View more
  13 in total

1.  Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.

Authors:  Samay Jain; Jayandra Himali; Alexa Beiser; Thanh G N Ton; Margaret Kelly-Hayes; Mary Lou Biggs; Joseph A C Delaney; Caterina Rosano; Sudha Seshadri; Samuel A Frank
Journal:  Am J Epidemiol       Date:  2014-12-29       Impact factor: 4.897

Review 2.  Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson's Disease.

Authors:  Milan Zimmermann; Kathrin Brockmann
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

4.  Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective Study.

Authors:  Michal Dufek; Irena Rektorova; Vojtech Thon; Jindrich Lokaj; Ivan Rektor
Journal:  Parkinsons Dis       Date:  2015-08-16

5.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

6.  Particulate matter and risk of Parkinson disease in a large prospective study of women.

Authors:  Natalia Palacios; Kathryn C Fitzgerald; Jaime E Hart; Marc G Weisskopf; Michael A Schwarzschild; Alberto Ascherio; Francine Laden
Journal:  Environ Health       Date:  2014-10-07       Impact factor: 5.984

7.  The Air We Breathe: Air Pollution as a Prevalent Proinflammatory Stimulus Contributing to Neurodegeneration.

Authors:  Monika Jankowska-Kieltyka; Adam Roman; Irena Nalepa
Journal:  Front Cell Neurosci       Date:  2021-06-24       Impact factor: 5.505

Review 8.  Can Gait Signatures Provide Quantitative Measures for Aiding Clinical Decision-Making? A Systematic Meta-Analysis of Gait Variability Behavior in Patients with Parkinson's Disease.

Authors:  Niklas König; Navrag B Singh; Christian R Baumann; William R Taylor
Journal:  Front Hum Neurosci       Date:  2016-06-30       Impact factor: 3.169

9.  Air Pollution and Risk of Parkinson's Disease in a Large Prospective Study of Men.

Authors:  Natalia Palacios; Kathryn C Fitzgerald; Jaime E Hart; Marc Weisskopf; Michael A Schwarzschild; Alberto Ascherio; Francine Laden
Journal:  Environ Health Perspect       Date:  2017-08-18       Impact factor: 9.031

10.  Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens.

Authors:  Büin Adams; J Massimo Nunes; Martin J Page; Timothy Roberts; Jonathan Carr; Theo A Nell; Douglas B Kell; Etheresia Pretorius
Journal:  Front Aging Neurosci       Date:  2019-08-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.